Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
BPC 157
Batch #
N/A
Formula
C62H98N16O22
Mol Wt
1419.5 g/mol
CAS
137525-51-0137525-51-0
Compound
KLOW
Batch #
N/A
Formula
C38H68N10O14
Mol Wt
889.0 g/mol
CAS
885340-08-9
Latest
ISO 17025
8× Testing
99.52%
Purity
VariantGHK-Cu / BPC-157 / TB-500 / KPV
COA ##12723
LabeledGHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), KPV (10mg)
Validation KeyAXISBIOTECH
Tested04/03/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.52%
✓
Net Peptide Content - GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), KPV (10mg)
✓
Identity (HPLC) - GHK-Cu / BPC-157 / TB-500 / KPV
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
02
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
03
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
04
KPV, an alpha-MSH-derived peptide, attenuates colon inflammation in mice via direct epithelial cell action
05
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
